On the recordFebruary 3, 2015
I have difficulty in understanding how the administration calls for a reduction in the patent protection for innovative, complex biologics from 12 years to 7.
Source
congress.govI have difficulty in understanding how the administration calls for a reduction in the patent protection for innovative, complex biologics from 12 years to 7.
Menendez questions the administration's stance on patent protections for biologics.
Share & report
More from Bob Menendez
As part of the Biden administration's efforts to strengthen OT ICS cybersecurity, it launched a series of sector-specific sprints.
The smooth and effective movement of cargo through the Port of New York and New Jersey is critical to our economy.
How would making these programs mandatory or formula-based impact planning for large-scale projects?